布莱顿标准在吉兰-巴雷综合征早期诊断和管理中的意义
Significance of Brighton Criteria in the Early Diagnosis and Management of Guillain-Barré Syndrome.
作者信息
Ghazanfar Haider, Qazi Rabia, Ghazanfar Ali, Iftekhar Sania
机构信息
Internal Medicine, Bronxcare Health System, Bronx, USA.
Medicine, Women Medical College Abbottabad, Abbottabad, PAK.
出版信息
Cureus. 2020 May 27;12(5):e8318. doi: 10.7759/cureus.8318.
Abstract
Guillain-Barré syndrome (GBS) is a rare but severe autoimmune disease and the usage of the Brighton criteria can be a source of great help in resource-limited settings. It encompasses all ages. Late diagnosis of GBS can have a significant negative impact on the prognosis. The Brighton criteria are used to assist in the diagnosis of GBS and help distinguish between low-risk and high-risk patients. In this article, we have discussed the challenges regarding the diagnosis of the GBS and the possible solutions that can help in the early diagnosis and management of GBS.
摘要
吉兰-巴雷综合征（GBS）是一种罕见但严重的自身免疫性疾病，在资源有限的环境中，使用布莱顿标准可能会有很大帮助。它涵盖所有年龄段。GBS的延迟诊断会对预后产生重大负面影响。布莱顿标准用于辅助GBS的诊断，并帮助区分低风险和高风险患者。在本文中，我们讨论了GBS诊断方面的挑战以及有助于GBS早期诊断和管理的可能解决方案。
相似文献
1
Significance of Brighton Criteria in the Early Diagnosis and Management of Guillain-Barré Syndrome.
Cureus. 2020 May 27;12(5):e8318. doi: 10.7759/cureus.8318.
2
Clinical Features and the Validation of the Brighton Criteria in Guillain-Barré Syndrome: Retrospective Analysis of 72 Hospitalized Patients in Three Years.
Eur Neurol. 2019;81(5-6):231-238. doi: 10.1159/000503101. Epub 2019 Oct 1.
3
A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria.
Iran J Neurol. 2019 Apr 4;18(2):64-69.
4
Guillain-Barré syndrome in Bangladesh: validation of Brighton criteria.
J Peripher Nerv Syst. 2016 Dec;21(4):345-351. doi: 10.1111/jns.12189.
5
[Clinical features of children with Guillain-Barré syndrome and the significance of Brighton criteria].
Zhongguo Dang Dai Er Ke Za Zhi. 2021 Feb;23(2):153-157. doi: 10.7499/j.issn.1008-8830.2009175.
6
Guillain-Barré syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity.
J Neurol. 2019 Feb;266(2):440-449. doi: 10.1007/s00415-018-9151-x. Epub 2018 Dec 7.
7
Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.
Brain. 2014 Jan;137(Pt 1):33-43. doi: 10.1093/brain/awt285. Epub 2013 Oct 26.
8
Management of Guillain-Barré syndrome in Bangladesh: Clinical practice, limitations and recommendations for low- and middle-income countries.
J Peripher Nerv Syst. 2023 Dec;28(4):564-577. doi: 10.1111/jns.12597. Epub 2023 Sep 24.
9
Diagnosis of Guillain-Barré syndrome in children and validation of the Brighton criteria.
J Neurol. 2017 May;264(5):856-861. doi: 10.1007/s00415-017-8429-8. Epub 2017 Mar 1.
10
Guillain-Barré syndrome subtypes: A clinical electrophysiological study of 100 patients.
Rev Neurol (Paris). 2019 Jan-Feb;175(1-2):73-80. doi: 10.1016/j.neurol.2018.01.379. Epub 2018 Nov 12.
引用本文的文献
1
Demographic and clinical characteristics of Guillain-Barré syndrome at Kenyatta National Hospital, Kenya.
BMJ Neurol Open. 2025 Jun 8;7(1):e001074. doi: 10.1136/bmjno-2025-001074. eCollection 2025.
2
Axonal Neuropathy in Hepatic Porphyria Should Not be Confused With Guillain-Barre Syndrome.
Neurohospitalist. 2025 May 9:19418744251342108. doi: 10.1177/19418744251342108.
3
Guillain-Barré syndrome (GBS) after severe/critical COVID-19 or COVID-19 vaccination.
Eur J Med Res. 2025 Feb 24;30(1):131. doi: 10.1186/s40001-025-02378-w.
4
Onset of Guillain Barré Syndrome in a Pregnant Woman: A Report of a Rare Occurrence.
Cureus. 2025 Jan 20;17(1):e77715. doi: 10.7759/cureus.77715. eCollection 2025 Jan.
5
Controversies in COVID-19: Diagnostic Evaluation and Management in Neuro-COVID.
Adv Exp Med Biol. 2024;1457:185-197. doi: 10.1007/978-3-031-61939-7_10.
6
Guillain-Barré Syndrome and Encephalitis Following a Cytomegalovirus Infection in an Immunocompetent Adult: A Case Report.
Am J Case Rep. 2024 Jul 18;25:e944337. doi: 10.12659/AJCR.944337.
7
The National Institutes of Health COVID-19 Neuro Databank/Biobank: Creation and Evolution.
Neuroepidemiology. 2024 Jun 26:1-13. doi: 10.1159/000539830.
8
A 'Decrescendo' in a Woman With Ascending Paralysis: A Diagnostic Challenge.
Cureus. 2024 May 1;16(5):e59479. doi: 10.7759/cureus.59479. eCollection 2024 May.
9
Evaluating algorithms for identifying incident Guillain-Barré Syndrome in Medicare fee-for-service claims.
Glob Epidemiol. 2024 May 3;7:100145. doi: 10.1016/j.gloepi.2024.100145. eCollection 2024 Jun.
10
A Response Letter to: Letter to the Editor Regarding "Anti-SARS-CoV-2 Vaccination Related Polyradiculitis Requires Early Diagnosis and Treatment to Improve the Outcome: Facts and Challenges During COVID-19 Pandemic".
Pulm Ther. 2023 Sep;9(3):455-457. doi: 10.1007/s41030-023-00236-w. Epub 2023 Jul 24.
本文引用的文献
1
Diagnosis of Guillain-Barré syndrome in children and validation of the Brighton criteria.
J Neurol. 2017 May;264(5):856-861. doi: 10.1007/s00415-017-8429-8. Epub 2017 Mar 1.
2
Guillain-Barré syndrome: a century of progress.
Nat Rev Neurol. 2016 Dec;12(12):723-731. doi: 10.1038/nrneurol.2016.172. Epub 2016 Nov 18.
3
Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.
Brain. 2014 Jan;137(Pt 1):33-43. doi: 10.1093/brain/awt285. Epub 2013 Oct 26.
4
Guillain-Barré Syndrome in India: population-based validation of the Brighton criteria.
Vaccine. 2011 Dec 6;29(52):9697-701. doi: 10.1016/j.vaccine.2011.09.123. Epub 2011 Oct 11.
5
The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review.
Neuroepidemiology. 2009;32(2):150-63. doi: 10.1159/000184748. Epub 2008 Dec 17.
Zotero 插件